AniƱon, Liezel B.
HRN: 21-19-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2022
AMPICILLIN 1GM (VIAL)
05/21/2022
05/28/2022
IVT
2g
Q6H
PROM X 12 Hours With Thinly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes